For the HCC, the first report was published very recently; glypican-3- (GPC3-) specific CAR-NK-92 cells showed potent antitumor activities in multiple HCC xenografts with both high and low GPC3 expressions. The gene discussed is GPC3; the disease is hepatocellular carcinoma.